Comparison of six-month outcome of coronary artery stenting in patients65, 65-75, and75 years of age
| Autor: | Thomas F. Peters, Yazan Khatib, Rodger P. Pinto, Cass A. Pinkerton, Tony K. Nasser, Charles M. Orr, Edward T.A. Fry, James W. Vantassel, Kingsley Annan, James B. Hermiller, Bruce F. Waller |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Male
medicine.medical_specialty medicine.medical_treatment Coronary Disease Balloon Angioplasty Internal medicine medicine Humans In patient Myocardial infarction Aged Retrospective Studies Aged 80 and over business.industry Age Factors Stent Middle Aged medicine.disease Coronary Vessels Surgery Survival Rate medicine.anatomical_structure Treatment Outcome Bypass surgery Cardiology Female Stents Cardiology and Cardiovascular Medicine Complication business Artery |
| Zdroj: | The American journal of cardiology. 80(8) |
| ISSN: | 0002-9149 |
| Popis: | We studied 1,238 patients receiving 1,880 coronary stents. In-hospital outcomes were divided by age into65 years (n = 747, group 1), 65 to 75 years (n = 326, group 2), and75 years (n = 165, group 3). Procedural success was 97.2%, 95.1%, and 98.8% in groups 1, 2, and 3, respectively (p = NS). There was 1 death (group 1). Myocardial infarction occurred in 1.2%, 2.8%, and 1.8%, bypass surgery occurred in 0.9%, 1.8%, and 1.2%, and repeat balloon angioplasty in 0.3%, 0.6%, and 0% of patients in groups 1, 2, and 3, respectively (p = NS for all comparisons). Vascular complications occurred in 2.8%, 4.9%, and 6.1% in groups 1, 2, and 3, respectively (p0.05). Six-month follow-up of patients was divided by age:65 years (n = 564, group 1); 65 to 75 years (n = 221, group 2); and75 years (n = 122, group 3). Event-free survival was 94.5%, 90.5%, and 89.3% for groups 1, 2, and 3, respectively (p = NS). Death occurred in 0.4%, 0.5%, and 1.6%; myocardial infarction occurred in 1.2%, 2.3%, and 1.6%, and target vessel revascularization in 4.3%, 8.6%, and 7.4% for groups 1, 2, and 3, respectively (p = NS for all comparisons). Thus, coronary stenting produced favorable in-hospital and 6-month outcomes in all 3 age groups. Age itself should not preclude patients from undergoing coronary stenting. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect